InfuSystem (NYSE:INFU) is a leading provider of comprehensive infusion pump and respiratory therapy services to healthcare providers across the United States and Canada. Founded in 1987 and headquartered in Lake Forest, Illinois, the company offers a full suite of rental, sales, service and managed care programs designed to support hospitals, oncology clinics, urology practices and ambulatory infusion centers. InfuSystem’s core business encompasses the supply and maintenance of a broad array of medical devices, including electronic infusion pumps, elastomeric devices, balloon pumps, syringe pumps and portable ventilators tailored to diverse clinical applications.
In addition to its robust rental and sales platform, InfuSystem delivers a range of value-added services such as device maintenance, calibration, inspection, preventive maintenance and end-of-life replacement programs. The company operates a nationwide network of repair and refurbishment facilities, ensuring rapid turnaround times and minimizing downtime for critical medical equipment. InfuSystem’s managed services programs streamline inventory management and regulatory compliance, enabling healthcare providers to focus on patient care while reducing administrative burdens and capital expenditures.
Over the years, InfuSystem has expanded its reach through strategic acquisitions and partnerships, broadening its product offerings and extending its service footprint. The company serves a diverse customer base that includes academic medical centers, community hospitals, outpatient facilities, home infusion providers and physician-owned clinics. With a dedicated team of field service engineers and remote technical support specialists, InfuSystem maintains a high level of responsiveness and personalized customer service.
Led by an experienced executive team with deep expertise in medical device logistics, service operations and healthcare technology integration, InfuSystem continues to innovate in equipment lifecycle management and patient-centric therapy solutions. The company’s ongoing investments in device connectivity, data analytics and telehealth capabilities underscore its commitment to enhancing clinical outcomes and operational efficiencies for healthcare providers.
